2020
DOI: 10.1016/j.healun.2020.01.839
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Statin Intensity in the Prevention of Cardiac Allograft Vasculopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…[ 18 ] Another report of 131 heart transplant patients found no association between high-intensity statins and the incidence of CAV at 1 or 3 years. [ 19 ] Although statin intensity has been associated with reduction in atherosclerotic cardiovascular disease in non-transplant patients, the effect of statin intensity on CAV reduction in the cardiac transplant population is still unknown. The primary aim of this study is to evaluate the effect of statin intensity on the time to the development of CAV after cardiac transplantation.…”
mentioning
confidence: 99%
“…[ 18 ] Another report of 131 heart transplant patients found no association between high-intensity statins and the incidence of CAV at 1 or 3 years. [ 19 ] Although statin intensity has been associated with reduction in atherosclerotic cardiovascular disease in non-transplant patients, the effect of statin intensity on CAV reduction in the cardiac transplant population is still unknown. The primary aim of this study is to evaluate the effect of statin intensity on the time to the development of CAV after cardiac transplantation.…”
mentioning
confidence: 99%